Due tonational shortageof the nebulization solutions, theformulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products willautomatically return to their original formulary status. SeeAlbuterol/Duoneb Shortage Mitigationfor more information. (UpdatedFeb 2023)
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
NOTES
ipratropium (Atrovent HFA) **PRN orders**
1-3 puffs PRN
ipratropium (Atrovent)
0.5 mg per nebulizer PRN ( at some dosage interval)
Exceptions --> PRN inhalers to be "kept at bedside" or "self-administered"
ipratropium (Atrovent HFA) **Scheduled orders**
1-2 inhalations TID-QID
ipratropium (Atrovent)
0.5 mg per nebulizer TID-QID (or at same dosing interval), 6 to 8 hours apart, maximum of 4 treatments/day
Due to national shortage of the nebulization solutions, the formulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products will automatically return to their original formulary status. See Albuterol/Duoneb Shortage Mitigation for more information. (Updated Feb 2023)
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
NOTES
ipratropium (Atrovent HFA) **PRN orders**
ipratropium (Atrovent)
Exceptions --> PRN inhalers to be "kept at bedside" or "self-administered"
ipratropium (Atrovent HFA) **Scheduled orders**
ipratropium (Atrovent)
ipratropium (Atrovent HFA) **acute asthama**
ipratropium (Atrovent) **nebulization**
Common Nebulized Doses for Pediatrics
Reviewed: December 16, 2014 (Atrovent HFA)